Esperion Therapeutics (ESPR) Prepaid Assets (2012 - 2026)

Esperion Therapeutics has reported Prepaid Assets for 15 years, with the latest figure at $5.8 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 20.27% year-over-year to $5.8 million; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (up 20.27% YoY), and the FY2025 full-year result was $4.5 million, up 8.21% from the prior year.
• Prepaid Assets for Q1 2026 stood at $5.8 million, up from $4.5 million in the prior quarter.
• The five-year high for Prepaid Assets was $9.9 million in Q4 2022, with the low at $193000.0 in Q4 2023.
• Historically, Prepaid Assets has averaged $4.2 million across 5 years, with a median of $4.4 million in 2023.
• Annual changes were most pronounced in 2023 — Prepaid Assets plunged 98.04% — and 2024, when it soared 2052.85%.
• Esperion Therapeutics' Prepaid Assets stood at $9.9 million in 2022, then slumped by 98.04% to $193000.0 in 2023, then soared by 2052.85% to $4.2 million in 2024, then advanced by 8.21% to $4.5 million in 2025, then increased by 28.8% to $5.8 million in 2026.
• The last three Prepaid Assets figures came in at $5.8 million (Q1 2026), $4.5 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.